Integration of molecular imaging in the personalized approach of patients with adrenal masses
- 1 May 2022
- journal article
- review article
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 66 (2), 104-115
- https://doi.org/10.23736/s1824-4785.22.03449-5
Abstract
Article: Integration of molecular imaging in the personalized approach of patients with adrenal masses - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 Mar 28 - Minerva Medica - JournalsKeywords
This publication has 86 references indexed in Scilit:
- Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal TumorsJournal of Clinical Endocrinology & Metabolism, 2011
- FDG PET in the Management of Patients with Adrenal Masses and Adrenocortical CarcinomaHormones and Cancer, 2011
- PET Imaging of CXCR4 Receptors in Cancer by a New Optimized LigandChemMedChem, 2011
- Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paragangliomaNuclear Medicine Communications, 2011
- AME Position Statement on adrenal incidentalomaActa Endocrinologica, 2011
- 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter TrialJournal of Nuclear Medicine, 2009
- Imaging of Neuroendocrine TumorsSeminars in Nuclear Medicine, 2006
- Adrenal Gland ScintigraphySeminars in Nuclear Medicine, 2006
- Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.American Journal of Roentgenology, 1995